| Market Capitalization (Millions $) |
348 |
| Shares
Outstanding (Millions) |
71 |
| Employees |
106 |
| Revenues (TTM) (Millions $) |
37 |
| Net Income (TTM) (Millions $) |
-65 |
| Cash Flow (TTM) (Millions $) |
15 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Foghorn Therapeutics Inc is a biotechnology company that focuses on developing precision medicines for patients with diseases caused by gene dysregulation. The company utilizes its proprietary Gene Traffic Control platform to gain insights into the role of chromatin regulation in gene expression and identify potential therapeutic targets. By targeting the complex mechanisms that control gene expression, Foghorn aims to develop innovative and transformative therapies for various diseases, including cancer and neurodegenerative disorders. The company is committed to advancing the understanding of gene regulation and translating their findings into novel treatments that have the potential to improve patient outcomes.
Company Address: 99 Coolidge Avenue, Suite 500 Watertown 2472 MA
Company Phone Number: 586-3100 Stock Exchange / Ticker: NASDAQ FHTX
|
0.38% 
120.33 %